Preoperative Potassium Predicts Hyperkalemia Post-Parathyroidectomy
Hyperkalemia commonly occurs after parathyroidectomy (PTx) in patients on maintenance hemodialysis (HD), according to recent research. Now new study findings published in BMC Nephrology suggest...
View ArticleParathyroid Hormone Predicts Fracture, Vascular Events, Death in CKD
In patients with chronic kidney disease (CKD) not on dialysis, elevated parathyroid hormone (PTH) levels correlate with an increased risk for fractures, vascular events, and death, Karen Hansen, MD,...
View ArticlePost-Parathyroidectomy Hungry Bone Syndrome Risk Factors ID’d
Hungry bone syndrome commonly occurs after parathyroidectomy with autotransplantation (PTx) in patients with secondary hyperparathyroidism on hemodialysis, and high preoperative serum alkaline...
View ArticleHolistic Approach to Managing SHPT Recommended for Older Adults
Little evidence exists on treating secondary hyperparathyroidism (SHPT) in adults older than 65 years. In a new review published in Drugs & Aging, the authors suggest nephrologists continue to...
View ArticleCalcitriol Loading May Not Prevent Post-PTx Hungry Bone Syndrome
Calcitriol loading before total parathyroidectomy (PTx) with autotransplantation in end-stage renal disease patients does not appear to prevent postoperative hypocalcemia, researchers of a small study...
View ArticleStudy: Higher-Dose Dialysate Calcium Better for SHPT
In patients on peritoneal dialysis (PD), 1.75 vs 1.25 mmol/L dialysate calcium is more effective at treating secondary hyperparathyroidism (SHPT), but the 1.25 mmol/L dose is better at easing...
View ArticleStudy: Adding Cinacalcet to Vitamin D Does Not Improve PTH
Cinacalcet in combination with vitamin D therapy has no effect on parathyroid hormone (PTH) levels in dialysis patients with secondary hyperparathyroidism (SHPT) compared with vitamin D alone, but the...
View ArticleMedication Use Low in Non-Dialysis CKD-MBD
Management of mineral bone disorders (MBD) in patients with non-dialysis chronic kidney disease (CKD) varies internationally, particularly with respect to target levels of biomarkers and use of...
View ArticleEarlier Parathyroidectomy May Ease Tumoral Calcinosis
Immediate parathyroidectomy (PTx) may be an effective treatment for hemodialysis patients with tumoral calcinosis due to secondary hyperparathyroidism (SHPT), according to investigators. Tumoral...
View ArticleThermal Ablation, Parathyroidectomy Show Similar Efficacy in SHPT
Thermal ablation and parathyroidectomy (PTx) both effectively treat secondary hyperparathyroidism (SHPT), according to new research published in the International Journal of Surgery. In a...
View ArticleHigh Predialysis PTH Predicts Increased Risk for Uncontrolled PTH
WASHINGTON—Patients who have elevated parathyroid hormone (PTH) levels before the onset of end-stage renal disease are more likely to be prescribed active vitamin D and calcimimetic therapy after they...
View ArticleGuidance on Cinacalcet Use in Pediatric Dialysis
The FDA has not yet approved use of the calcimimetic cinacalcet in children receiving dialysis. In the absence of formal guidelines, the European Society for Paediatric Nephrology, Chronic Kidney...
View ArticleTimely Parathyroidectomy Urged in KTRs With Hyperparathyroidism
Timely parathyroidectomy (PTx) that avoids removal of too much parathyroid tissue may help preserve renal graft function among kidney transplant recipients with hyperparathyroidism by avoiding steep...
View ArticleCinacalcet Effective in Young Children on Dialysis
Cinacalcet, a calcimimetic used to treat secondary hyperparathyroidism (SHPT) in adults, also appears relatively safe and effective for children younger than 5 years receiving maintenance dialysis,...
View ArticleSecondary Hyperparathyroidism Associated With Worsening Symptoms
Patients with secondary hyperparathyroidism (SHPT) experience worsening of certain symptoms as parathyroid hormone (PTH) levels increase, new data suggest. Investigators asked 165 patients with SHPT...
View ArticleSHPT Outcomes Similar for Oral Calcitriol vs IV Vitamin D
Switching from an intravenous (IV) vitamin D analog to oral calcitriol results in no worse outcomes in patients with secondary hyperparathyroidism (SHPT) on maintenance hemodialysis (HD), new study...
View ArticleNew Calciphylaxis Risk Factor Identified
Unintentional weight loss, obesity, and use of vitamin K antagonists (VKA) are among the risk factors for calciphylaxis in patients on hemodialysis (HD), according to new study findings from a...
View ArticleHigh Levels of Calcium, Phosphate in SHPT Ups Death Risk
Hemodialysis (HD) patients with secondary hyperparathyroidism (SHPT) who have high serum calcium and phosphate levels have greater risks for death than patients with values in the normal range,...
View ArticleDenosumab May Slow Coronary Artery Calcification in Severe SHPT
Denosumab, an osteoporosis drug, may slow progression of coronary artery calcification (CAC) and potentially reverse osseous calcification in patients with secondary hyperparathyroidism (SHPT) who...
View ArticleThrice-Weekly Cinacalcet Possibly Effective in HD
Administering the oral calcimimetic cinacalcet thrice weekly instead of once daily in hemodialysis (HD) patients may be effective for treating secondary hyperparathyroidism (SHPT), according to new...
View Article
